These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6938949)

  • 21. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.
    Brier S; Pflieger D; Le Mignon M; Bally I; Gaboriaud C; Arlaud GJ; Daniel R
    J Biol Chem; 2010 Oct; 285(42):32251-63. PubMed ID: 20592021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the C1r-C1s interaction of the C1 complex of complement activation.
    Almitairi JOM; Venkatraman Girija U; Furze CM; Simpson-Gray X; Badakshi F; Marshall JE; Schwaeble WJ; Mitchell DA; Moody PCE; Wallis R
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):768-773. PubMed ID: 29311313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.
    Arlaud GJ; Reboul A; Sim RB; Colomb MG
    Biochim Biophys Acta; 1979 Jan; 576(1):151-62. PubMed ID: 760802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.
    Sim RB; Porter RR; Reid KB; Gigli I
    Biochem J; 1977 May; 163(2):219-27. PubMed ID: 869924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement.
    Gregory LA; Thielens NM; Arlaud GJ; Fontecilla-Camps JC; Gaboriaud C
    J Biol Chem; 2003 Aug; 278(34):32157-64. PubMed ID: 12788922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
    Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of the complement (C1r/C1s/MASP2-like serine proteases from the common carp (Cyprinus carpio).
    Nakao M; Osaka K; Kato Y; Fujiki K; Yano T
    Immunogenetics; 2001; 52(3-4):255-63. PubMed ID: 11220628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quaternary structure in solution of human complement subcomponent C1r2C1s2.
    Perkins SJ; Nealis AS
    Biochem J; 1989 Oct; 263(2):463-9. PubMed ID: 2556995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A molecular dynamics study of C1r and C1s dimers: implications for the structure of the C1 complex.
    Beveridge AJ; Wallis R; Samani NJ
    Proteins; 2012 Aug; 80(8):1987-97. PubMed ID: 22488778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
    Sim RB; Arlaud GJ; Colomb MG
    Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes.
    Bartholomew RM; Esser AF
    Biochemistry; 1980 Jun; 19(13):2847-53. PubMed ID: 6772208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.
    Perkins SJ
    Biochem J; 1985 May; 228(1):13-26. PubMed ID: 2988513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.